Search results for " chad"

showing 4 items of 4 documents

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overvi…

2021

To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vaxzevria (previously COVID-19 Vaccine AstraZeneca). Although the benefit–risk profile of these vaccines was proven to be largely favourable in the general population, evidence in special cohorts initially excluded from the pivotal trials, such as pregnant and breastfeeding women, children/adolescents, immunocompromised people and persons with a history of allergy or previous SARS-CoV-2 infection, is still limited. In this narrative review, we critically overv…

AllergyIMPACTCOVID-19 VaccineBreastfeedingReview ArticleToxicologySettore MED/42 - Igiene Generale E ApplicataCLINICAL CHARACTERISTICSPregnancyPharmacology (medical)Pregnancy Complications InfectiousChildOUTCOMESeducation.field_of_studyCANCERVaccinationEuropeCORONAVIRUS DISEASE 2019 CLINICAL CHARACTERISTICS CANCER RECIPIENTS SEVERITY OUTCOMES IMPACT RATESBreast FeedingChild PreschoolPractice Guidelines as TopicFemale2019-nCoV Vaccine mRNA-1273HumanAdultmedicine.medical_specialtyCOVID-19 Vaccines2019-nCoV Vaccine mRNA-1273; Adolescent; Adult; BNT162 Vaccine; Breast Feeding; COVID-19; COVID-19 Vaccines; ChAdOx1 nCoV-19; Child; Child Preschool; Europe; Female; Humans; Infant; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications Infectious; SARS-CoV-2; Hypersensitivity; Immunocompromised HostAdolescentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationMEDLINECORONAVIRUS DISEASE 2019Immunocompromised HostChAdOx1 nCoV-19medicineHypersensitivityHumansRATESeducationBNT162 VaccinePharmacologyPregnancybusiness.industrySARS-CoV-2COVID-19Infantmedicine.diseaseVaccine efficacyRECIPIENTSSEVERITYFamily medicinePregnancy Complications Infectioubusiness
researchProduct

Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

2021

This case report describes a fatal case of a young woman with superior sagittal, transverse and sigmoid sinus thrombosis after administration of the ChAdOx1 nCov-19 vaccination. Eleven days post-vaccination she was found unconscious and transferred to the Emergency Department. Blood parameters showed low platelets, and a CT scan showed an extensive left intracranial hemorrhage and the presence of an occlusive thrombus of the superior sagittal sinus. She under-went a craniectomy, but after the intervention, she remained in a comatose state. After a few days, her clinical conditions worsened, and she died. A complete autopsy was performed which showed a thrombosis of the cerebral venous distr…

Thrombotic cerebral sinusAdultPost-mortem investigationCOVID-19Cell BiologyThrombotic thrombocytopeniaSinus ThrombosisIntracranialThrombocytopeniaPathology and Forensic MedicineSinus Thrombosis IntracranialFatal OutcomeAutopsy ChAdOx1 nCov-19 vaccination Post-mortem investigation Thrombotic cerebral sinus Thrombotic thrombocytopenia VaccineChAdOx1 nCoV-19HumansFemaleAutopsyChAdOx1 nCov-19 vaccinationVaccinePathology - Research and Practice
researchProduct

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia

2021

Greinacher et al.1 and Schultz et al.2 were the first to independently report the main clinical and laboratory features of 11 and five respective patients from Germany, Austria and Norway who developed life-threatening thrombohemorrhagic complications 5 to 16 days after the administration of the first dose of the chimpanzee adenoviral vector vaccine ChAdOx1nCoV-19 against SARS-CoV-2 and COVID-19. Subsequently Scully et al.3 reported similar findings in 23 patients treated with the same vaccine in the United Kingdom. More recently, See et al.4 reported a case series of 12 patients from the USA with cerebral venous sinus thrombosis following the vaccination with Ad26.CoV2.S employing a human …

Vaccinesmedicine.medical_specialtybusiness.industrySARS-CoV-2thrombotic thombocytopeniavaccine ChAdOx1nCoV-19MEDLINECOVID-19ThrombosisAutopsyCase ReportHematologymedicine.diseaseThrombosisAntiviral AgentsInternal medicineMedicineHumansAutopsybusinessPandemicsHaematologica
researchProduct

A new Lagomorph from the late Miocene of Chad (central Africa)

2007

A new species of the genus Serengetilagus, here named S. tchadensis n. sp., is described from Toros Menalla deposits, Late Miocene of Djurab Erg (North Chad, central Africa). It shows primitive features, such as a simple archaeolagine-type p3, with only two main external folds, and upper cheek teeth strongly widened with wear. Its size and skeletal features resemble S. praecapensis from the Middle Pliocene of Laetoli (Tanzania). They differ in several cranial and dental features (choanae width, zygoma, orbits, basicranial-basifacial angle, lack of hypoflexus in P2, short and asymmetric hypoflexus in P3-M2, lack of lingual folds in p3, etc). Individual variations in S. tchadensis n. sp. appr…

geographySubfamilygeography.geographical_feature_categoryHypolagusbiologyPaleontologyCentral africaLate Miocenebiology.organism_classificationQE701-760late miocene chad africa mammalia leporidae serengetilagus phylogeny mode of life.PaleontologyErg (landform)PhylogeneticsGenus[SDU.STU.PG] Sciences of the Universe [physics]/Earth Sciences/Paleontology[SDU.STU.PG]Sciences of the Universe [physics]/Earth Sciences/PaleontologyComputingMilieux_MISCELLANEOUS
researchProduct